let's get some perspective on this now with simon clarke an associate professor in cellular microbiology at the university of reading in the u.k. welcome to d.w. you've written about the case numbers of the delta mainland brazil being partly attributed to the local variant they're called one can you tell us what makes this new taishan so dangerous. well it seems to spread quite quickly. and it also seems to be have such some sort of resistance to any tricks of state immunity there's also suggestions that some of the back seat on less effective as well so it seems to it really made it so bad a jump. but less sensitive than versions we've had before when it encounters enemy response which of course would sterilize the real me the infection i'm going on so in normal circumstances can you tell us more about the fact you mentioned that it could be partially resistant to the existing vaccines because needless to say that is very troubling so what is the data actually say on that. well age that suggests that the antibodies that are produced in response to an infection as part of one's immunity

member states and many other countries to respond simon clark does this also expose a certain hypocrisy on the part of the drugs companies astra zeneca we're talking about today but also the commission seems to me that what they should be doing is one fixing covert to fixing coded 3 fixing cove it instead of going to court primacy seems to be that the european commission is a bit ticked off because the contract wasn't what it should have been whereas if they fixed cove it they could then go on to help other countries such as india which are really heading into such a bad place right now. but i think this is really a political question rather than one of the pharmaceutical companies it's not really a business question because they are producing at quite a rates as much vaccine as they possibly can you know conscious flip a switch these things but it takes months to produce these vaccines a batch of these vaccines they can just be churned out you know it may be the next few days so maybe there is only so much they can do they are invested in production facilities and of course you have to

we have simon clark associate professor in cellular microbiology at the university of reading in grenoble in france barry pradelle ski associate professor of economics at the national center for scientific research and inverts berger many. political analyst and a huge on one a professor at stanford university in berlin welcome all of you to the program rick let me start with you today so the world health organization has sharply criticized europe's vaccine rollout as unacceptably slow just how bad is the situation currently and how much could this potentially be prolonging the pandemic in europe . well of course it would be much better if we would had blue print that we quit apply from previous examples but this is not the case it's the 1st time that the european union as a coordinating body is responsible for something like managing a pandemic and what are we discussing your of is that it makes much more sense to join forces and to prepare everything collectively but as it turns out this is much slower and fall less effective than what we can experience in israel in the united kingdom or

all right thank you so much for those insights simon clark associate professor in seattle or microbiology at the university of reading for soccer news now and there were 2 champions league quarter final 1st legs played on tuesday night manchester city hosted burson dortmund the german team suffered some heartbreak when still photos scored in the 90th minute to give city the win meanwhile young plus liverpool club were completely outplayed and real madrid the reds will have to make up a 31 deficit in the return leg. tonight one quarter final in the champions league sees cup holders byron munich host paris centrum on the team they defeated in the last scene of season's final a byron is looking to successfully defend their title they were suffered a major blow going into this match the club's top striker. has been sidelined due to injury and he is not the only byron player that will miss the action. a career season in the making for robert live and all ski has been put on hold by after the striker got injured during the international break with poland. does so of course robert is a very impo

we have simon clark at the university of reading in new delhi, and the chairperson at the center of socialine and community health, and in copenhagen, the head of health systems at the barcelona institute for global health. gentlemen, welcome. jeff, coming to you first. what is to be game for the people of europe if the european commission goes to court? jeff: i am not sure there is much to gain. this is a diversion from the real problem, a lack of doses. we need to focus on increasing production. i don't know if the eu is looking to recover funds or divert doses from where astrazeneca vaccine is being supplied elsewhere. if that is the case, i understand, but it does not make sense because it is a global pandemic, and as long as the doses are being used, that is the top priority. the eu is producing and very few countries, so we need to up the production capacity. anchor: simon, is this political point scoring? simon: it does seem to be, yes. you have to ask yourself after efforts to discredit the astrazeneca vaccine in terms of its efficacy, safety, why parts of europe are so keen to get

countries assigned secret contracts to get more vaccines microbiologist at reading university simon clarke also believes that that's the case. we have seen other countries go out broncho beyond. the common policy to use their economic position to be able to get hold of extra vaccine so there is you know they're up there taking their share of the common european purchase and then topping that up on their own so what we see is situation where there is not equal distribution of vaccines across europe which is the whole point of. common purchasing practice in the 1st place. google misled users in australia about collecting their personal location data that's the ruling that came from the countries federal court and it could land the tech giant with an enormous fine australia's fair trade watchdog which of fog a lawsuit to cloud the ruling a world 1st and said it has a very clear message that all digital platforms what the court found was that google misled consumers into thinking that if they turned off location history then that would stop google storing and keeping or collecting and keeping

and higher costs kimberly clark's first quarter earnings and revenue came up short and the company lowered its profit outlook with 91 days before the summer olympics, gymnast simoneching teams and leaving nike for a new sponsorship with athleta. she's getting her own line of performance wear and athleta will support a platform for her to be an activist for her and fellow athletes. >> big move. thank you very much for that >>> snap out with q1 results julia has a breakdown of the number what a year for snap up nearly 270% over the last 12 months >> that's right. that stock moving higher this morning after the company reported its fastest user and revenue growth in over three years in the first quarter as its investments in content and different technology tools are paying off the company added 15 million daily active users with growing engagement with its spotlight content, featured user content and 40% increase in daily engagement with augmented reality lenses the ceo saying augmented reality has huge potential to drive e-commerce down the line the company also shared a bullish advertising outlook despite the potential for apple's operating system to limit ad tar